GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
The FTSE 250 business's stock jumped 4.7%, or 6.3p, to 141.8p as investors bet it could be next food delivery group to be ...
Evening Standard on MSN22h
FTSE 100 Live 24 February: Just Eat backs £3.4bn takeover, B&M profit downgrade as boss quitsTwo former FTSE 100 stocks were in the spotlight today after Just Eat Takeaway.com backed a £3.4 billion takeover and B&M ...
GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.
Stock prices in London opened mostly flat on Monday, while across the channel Germany's election results have sparked uncertainty but also hopes of economic stimulus. The FTSE 100 index opened down 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback